期刊文献+

5,10-亚甲基四氢叶酸还原酶基因C677T突变与再发脑梗死的关系 被引量:3

The relationship between C677T mutation of 5,10-methylenetetrahydrofolate reductase and recurrent cerebral infarction
原文传递
导出
摘要 目的探讨5,10-亚甲基四氢叶酸还原酶(MTHFR)基因C677T突变与再发脑梗死的关系。方法收集脑梗死患者及对照组的血液标本,采用聚合酶链式反应-限制性片段长度多态性分析法分析其MTHFR基因C677T突变。结果初发脑梗死组MTHFR基因C677T突变率为68.0%,再发脑梗死组突变率为69.5%,均高于对照组46.3%,差异均有显著性(P<0.05);初发脑梗死组与再发脑梗死组MTHFR基因C677T突变率没有显著性差异(P>0.05)。结论MTHFR基因C677T突变可能与脑梗死的发病有关,但与脑梗死发病的次数无关。 Objective To explore the relationship between C677T mutantion of 5,10-methylenetetrahydrofolate reductase (MTHFR) and recurrent cerebral infarction. Methods Blood samples were collected from the cerebral infarction patients and controls. The CA77T mutation of MTHFR was determined by the method of polymerase chain reaction and restriction fragment length polymorphism. Results The CA77T mutant frequencies of MTHFR in group of both primary and recurrent cerebral infarction were 68. 0 % and 69. 5 % respectively which were higher (P〈0. 05) than that in controls 33. 8%. The C677T mutant frequencies of MTHFR in group of both primary and recurrent cerebral infarction had no significant difference(P〉0. 05). Conclusions The C677T mutant frequency of MTHFR might be correlated only with cerebral infarction but not with the frequency of onset of cerebral infarction.
出处 《卒中与神经疾病》 2007年第1期10-12,共3页 Stroke and Nervous Diseases
关键词 再发脑梗死 5 10-亚甲基四氢叶酸还原酶 基因突变 Recurrent cerebral infarction 5,10-methylenetetrahydrofolate Reductase Gene mutation
  • 相关文献

参考文献4

二级参考文献27

  • 1毕胜,王德生,张昱,吴江,盛雨辰,赵庆杰,潘尚哈.血管性痴呆患者与其血浆同型半胱氨酸水平的关系[J].中华老年心脑血管病杂志,2000,2(5):318-321. 被引量:17
  • 2黄一宁,高山,王莉鹃,汪波.闭塞性脑血管病经颅多谱勒超声和脑血管造影的比较[J].中华神经科杂志,1997,30(2):98-101. 被引量:176
  • 3Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker.Dement Geriatr Cogn Disord, 1999, 10 (1)12-20.
  • 4Colleen J, Maxwell, David B. et al. Serum Folate Levels and Subsequent Adverse Cerebrovascular Outcomes in Elderly Persons. Dement Geriaer Cogn Disord, 2002,13(4) :225-234.
  • 5McIlcoy SP, Dynan KB, Lawson JT, et al. Moderately Elevated Plasma Homocysteine, Methylenetetrahydrofolate Reductase Genotype, and Risk for Stroke, Vascular Dementia, and Alzheimer Disease in Northern Ireland. Stroke, 2002,33 (10):2351-2356.
  • 6Mariano M Raffaele F Rita B et al. Homocysteine, vitamin B12 and folate in vascular in vascular dementia and in Alzheimer disease. Clin Chem Lab Med, 2004, 42 (9):1032-1035.
  • 7Quadri P, Fragiacomo C, Pezzati R,et al.Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr,2004,80(1): 114-122.
  • 8Ebly EM, Schaefer JP, Campbell NR, et al. Folate status,vascular disease and cognition in elderly Canadians. Age and Aging, 1998,27 ( 7 ): 485-491.
  • 9Leblhuber F, Walli J, Artner-Dworzak E,et al. Hyperhomocysteinemia in dementia.J Neural Transm, 2000, 107 ( 12 ): 1469-1474.
  • 10Gottfries CG, Lehmann W, Regland B.Early diagnosis of cognitive impairment in the elder with the focus on Alzhemer'disease. J Neural Transm, 1998,105(8-9):773-786.

共引文献126

同被引文献13

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部